MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, J. E.
Right arrow Articles by Perez, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, J. E.
Right arrow Articles by Perez, D. M.

Vol. 53, Issue 4, 766-771, April 1998

The Agonism and Synergistic Potentiation of Weak Partial Agonists by Triethylamine in alpha 1-Adrenergic Receptor Activation: Evidence for a Salt Bridge as the Initiating Process

James E. Porter, Stephanie E. Edelmann, David J. Waugh, Michael T. Piascik, and Dianne M. Perez

Department of Molecular Cardiology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195 (J.E.P., D.J.W., D.M.P.) and Department of Pharmacology, College of Medicine, University of Kentucky, Lexington, Kentucky 40536 (S.E.E., M.T.P.).

alpha 1-adrenergic receptor (AR) activation is thought to be initiated by disruption of a constraining interhelical salt bridge (). Disruption of this salt bridge is achieved through a competition for the aspartic acid residue in transmembrane domain three by the protonated amine of the endogenous ligand norepinephrine and a lysine residue in transmembrane domain seven. To further test this hypothesis, we investigated the possibility that a simple amine could mimic an important functional group of the endogenous ligand and break this alpha 1-AR ionic constraint leading to agonism. Triethylamine (TEA) was able to generate concentration-dependent increases of soluble inositol phosphates in COS-1 cells transiently transfected with the hamster alpha 1b-AR and in Rat-1 fibroblasts stably transfected with the human alpha 1a-AR subtype. TEA was also able to synergistically potentiate the second messenger production by weak partial alpha 1-AR agonists and this effect was fully inhibited by the alpha 1-AR antagonist prazosin. However, this synergistic potentiation was not observed for full alpha 1-AR agonists. Instead, TEA caused a parallel rightward shift of the dose-response curve, consistent with the properties of competitive antagonism. TEA specifically bound to a single population of alpha 1-ARs with a Ki of 28.7 ± 4.7 mM. In addition, the site of binding by TEA to the alpha 1-AR is at the conserved aspartic acid residue in transmembrane domain three, which is part of the constraining salt bridge. These results indicate a direct interaction of TEA in the receptor agonist binding pocket that leads to a disruption of the constraining salt bridge, thereby initiating alpha 1-AR activation.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. E. Porter and D. M. Perez
Influence of a Lysine 331 Counterion on the pKa of Aspartic Acid 125: Evidence for a Salt-Bridge Interaction and Role in alpha 1b-Adrenergic Receptor Activation
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 440 - 448.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. E. Porter and D. M. Perez
Characteristics for a Salt-bridge Switch Mutation of the alpha 1b Adrenergic Receptor. ALTERED PHARMACOLOGY AND RESCUE OF CONSTITUTIVE ACTIVITY
J. Biol. Chem., December 3, 1999; 274(49): 34535 - 34538.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. J. J. Waugh, R. J. Gaivin, D. S. Damron, P. A. Murray, and D. M. Perez
Binding, Partial Agonism, and Potentiation of alpha 1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1164 - 1171.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Chen, M. Xu, F. Lin, D. Lee, P. Riek, and R. M. Graham
Phe310 in Transmembrane VI of the alpha 1B-Adrenergic Receptor Is a Key Switch Residue Involved in Activation and Catecholamine Ring Aromatic Bonding
J. Biol. Chem., June 4, 1999; 274(23): 16320 - 16330.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics